ISLA-101 Phase 2a/b PROTECT Clinical Trial Progress Update
Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or ...
In
Investing
Spodumene Pegmatite Discovery at Esperança Project in Brazil Yields LIBS Results up to 4.04% Li2O
Lightning Minerals (L1M or the Company) is delighted to announce the discovery ...
Notice of Initial Substantial Holder – Regal Funds Management Pty Ltd
Provaris Energy Ltd (ASX.PV1, Provaris, the Company) is pleased to present the ...
Radiopharm Theranostics CEO Shares Company Milestones as NASDAQ Listing Nears
Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm ...
BPH Energy LimitedInvestee Cortical Dynamics Presentation
Perth, Australia (ABN Newswire) – BPH Energy Limited (ASX:BPH) provide a presentation ...
Positive Feasibility Study Demonstrates Profitable Magnet Recycling Business in UK
Ionic Rare Earths Limited (“IonicRE” or the “Company”) (ASX: IXR) wholly owned ...
68Ga-RAD 301 (68Ga-Trivehexin) Demonstrates Strong Potential for Imaging of αvβ6-Integrin Expression in Pancreatic Cancer Patients
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused ...
